A closer look at the function and efficicacy of niraparib as a maintenace treatment.
Good to know
-
July 11, 2018
-
May 31, 2018
There are a number of medicines available for melanoma patients. In this article we examine one newer medicine and discuss it's efficacy and use.
-
May 11, 2018
The European Medicines Agency has recently approved Niraparib (Zejula) for use in the European Union as a treatment for women struggling with a specific type of advanced ovarian cancer known as high-grade serous epithelial ovarian cancer, which includes cancers that affect the peritoneum and/or the fallopian tubes.
-
When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it. -
February 13, 2018
In 2015, an estimated 221,200 people in the U.S. will be diagnosed with lung cancer, which is 13 percent of all cancer diagnoses.
-
November 17, 2017
We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...
-
October 27, 2017
Why every little package is a big deal
-
October 20, 2017
How effective is alectinib (Alecensa)? The latest news and updates
-
October 17, 2017
We live in an age where you can hop online to order a new brand of lipstick if it hasn’t been released yet in your country.
-
September 20, 2017
Suggestions from cancer survivors and their children
-
September 04, 2017
Online counsellor Nicole Hind shares how to help our brains and bodies deal with a diagnosis.
-
September 04, 2017
An easy-to-understand infographic displaying the results from the clinical trial
-
For US patients and patients worldwide with ALS.
-
June 01, 2017
What did we get up to, and what's next?
-
Get the latest news on MS research, the FDA approval of Ocrevus (ocrelizumab) for both relapsing and progressive forms of MS, insights and resources.